Clinical leaders at the Faulkner-Sagoff Breast Imaging and Diagnostic Centre have commenced a research study involving a select group of 200 women at high risk for developing breast cancer. The high risk group includes women with dense breast tissue and either one or more first degree relatives with breast cancer or a recognized mutation in the breast genes (e.g., BRCA1 and BRCA2). The study is examining the outcomes of screening utilizing breast MRI versus mammography in breast cancer detection.

Dr. Sadowsky stated, " MRI is proving to be of value in women with dense breast tissue where mammography's limitations are well known. Utilizing a dedicated breast imaging system gives us hope for women whose cancers can go undetected by mammography."

Subject participants are being screened using the Aurora Breast Imaging System, New England's first dedicated breast magnetic resonance imaging (MRI) system approved by the Food and Drug Administration (FDA) in 1996 and manufactured by Aurora Imaging Technology, Inc., North Andover, MA.